Grethe Nørskov Rasmussen

Corporate Officer/Principal at FLUOGUIDE A/S

Net worth: 2 M $ as of 29/04/2024

62 year

100 connections

Health Technology

Commercial Services

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Lars Fruergaard Jorgensen	M	58	NOVO NORDISK A/S	33 years
Albert Cha	M	51	ASCENDIS PHARMA A/S	10 years
Peter Morch Eriksen	M	64	FLUOGUIDE A/S	5 years
Andreas Kjaer	M	61	FLUOGUIDE A/S	6 years
Shomit Ghose	M	63	FLUOGUIDE A/S	5 years
Scott Smith	M	50	ASCENDIS PHARMA A/S	8 years
Lars Holtug	M	66	ASCENDIS PHARMA A/S	6 years
Peter Rasmussen	M	55	ASCENDIS PHARMA A/S	10 years
Lisa Bright	F	56	ASCENDIS PHARMA A/S	7 years
Karsten Munk Knudsen	M	53	NOVO NORDISK A/S	25 years
Henrik Ehlers Wulff	M	54	NOVO NORDISK A/S	25 years
Morten Albrechtsen	M	60	FLUOGUIDE A/S	6 years
Micaela Sjökvist	F	54	FLUOGUIDE A/S	5 years
Mats Johan Peter Thorén	M	53	FLUOGUIDE A/S	3 years
Camilla Sylvest	F	52	NOVO NORDISK A/S	28 years
Maziar Mike Doustdar	M	54	NOVO NORDISK A/S	32 years
Flemming Steen Jensen	M	63	ASCENDIS PHARMA A/S	9 years
Ole Larsen	M	59	FLUOGUIDE A/S	1 years
Michael Engsig	M	-	FLUOGUIDE A/S	1 years
Dorthe Gronnegaard Mejer	F	49	FLUOGUIDE A/S	4 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Jakob Riis	M	58	NOVO NORDISK A/S	21 years
Martin Olin	M	55	ASCENDIS PHARMA A/S NOVO NORDISK A/S	9 years
Christian Hansen	M	58	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. NOVO NORDISK A/S Technical University of Denmark	11 years
Thomas Soloway	M	55	ASCENDIS PHARMA A/S	5 years
James Sulat	M	73	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	10 years
Rafaèle Elisabeth Tordjman	M	54	ASCENDIS PHARMA A/S	10 years
Birgitte Volck	M	61	ASCENDIS PHARMA A/S	7 years
Peder Holk Nielsen	M	67	NOVO NORDISK A/S Technical University of Denmark	10 years
Thomas Videbaek	M	63	Technical University of Denmark	5 years
Torben Nissen	M	53	ASCENDIS PHARMA A/S Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	3 years
Carsten Hellmann	M	60	NOVO NORDISK A/S	-
Birgitte Skou Holck-Andersen	M	67	Technical University of Denmark	4 years
Søren Thuesen Pedersen	M	59	Technical University of Denmark NOVO NORDISK A/S	29 years
Per Falholt	M	65	Technical University of Denmark NOVO NORDISK A/S	18 years
Jan Mikkelsen	M	65	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. NOVO NORDISK A/S	14 years
Mette Dobel	F	57	Technical University of Denmark	5 years
John M. Borkholder	M	55	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	8 years
Egill Jónsson	M	67	Technical University of Denmark	1 years
Arne Ferstad	M	74	FLUOGUIDE A/S	2 years
Gudmund Knudsen	M	-	Technical University of Denmark	5 years
Henrik Schimmell	M	62	Technical University of Denmark	5 years
Jack Nielsen	M	60	NOVO NORDISK A/S Technical University of Denmark	12 years
Harry Penner	M	78	NOVO NORDISK A/S	8 years
Louis Lange	M	72	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	8 years
Kurt Anker Nielsen	M	78	NOVO NORDISK A/S	13 years
Jonathan Silverstein	M	57	ASCENDIS PHARMA A/S	-
Jesper Brandgaard	M	60	NOVO NORDISK A/S	20 years
Kåre Schultz	M	62	NOVO NORDISK A/S	26 years
Mads Krogsgaard Thomsen	M	63	NOVO NORDISK A/S	30 years
James Healy	M	59	ASCENDIS PHARMA A/S	8 years
Ernest Mario	M	85	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	12 years
Elliot Goldstein	M	73	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	6 years
Thomas Kähler	M	53	Technical University of Denmark	4 years
Joan Schmidt	F	60	NOVO NORDISK A/S	20 years
Carmen Valcarce	M	-	NOVO NORDISK A/S	-
Eva Berneke	F	55	Technical University of Denmark	4 years
Thomas Lethenborg	M	55	Technical University of Denmark	5 years
Tina Sejersgård Fanø	F	55	Technical University of Denmark	4 years
Christopher Yallop	M	-	NOVO NORDISK A/S	6 years
Lars Green	M	57	NOVO NORDISK A/S	27 years
Jan Behrendt Ibsoe	M	-	Technical University of Denmark	1 years
Gitte L. Pedersen	F	61	NOVO NORDISK A/S	10 years
Charlotte Dyring	M	56	Technical University of Denmark	4 years
Henrik Dalsgard	M	-	Technical University of Denmark	3 years
Michael Troensegaard Andersen	M	63	Technical University of Denmark	-
Anders Heine Jensen	M	60	Technical University of Denmark	5 years
Hong Jiang Zhang	M	63	Technical University of Denmark	5 years
Anna Héléne Barnekow	F	60	NOVO NORDISK A/S	2 years
Liselotte Hyveled	F	58	NOVO NORDISK A/S	26 years
Gustav Christen Mellentin	M	58	Technical University of Denmark	5 years
Annette Stube	F	57	NOVO NORDISK A/S	11 years
Christoffer Leif Feilberg	M	-	Technical University of Denmark	5 years
Kaspar von Meyenburg	M	-	Technical University of Denmark	9 years
Robert Frederick Caspari	M	78	NOVO NORDISK A/S	4 years
Bo Pedersen	M	-	Technical University of Denmark	3 years
Lars Boettern	M	-	Technical University of Denmark	4 years
Valeta A. Gregg	M	72	NOVO NORDISK A/S	5 years
Peter David Suzdak	M	65	NOVO NORDISK A/S	7 years
Jan Ulf Sigvar J. Johansson	M	79	NOVO NORDISK A/S	7 years
Anders Hove	M	58	Technical University of Denmark	6 years
Claus Tycho Bræstrup	M	79	NOVO NORDISK A/S	10 years
Lars Kongsbak	M	63	Technical University of Denmark	3 years
Steve Wang	M	-	Technical University of Denmark	3 years
C. Ahlefeldt-Laurvig	M	-	Technical University of Denmark	1 years
Carsten Bjerg	M	64	Technical University of Denmark	4 years
Christian Gröndahl	M	60	NOVO NORDISK A/S	14 years
Jens Maaløe	M	69	Technical University of Denmark	3 years
Casper Breum	M	57	Technical University of Denmark	5 years
Steen Riisgaard	M	73	NOVO NORDISK A/S	21 years
Christian V. Olgaard	M	-	Technical University of Denmark	10 years
Leif Kongerslev	M	71	NOVO NORDISK A/S	-
Stig Strøbæk	M	60	NOVO NORDISK A/S	30 years
Peter Ruhdal Jensen	M	-	Technical University of Denmark	3 years
Bo Stig Hansen	M	-	Technical University of Denmark	13 years
Gorm Heron	M	-	Technical University of Denmark	1 years
René Svendsen-Tune	M	69	Technical University of Denmark	4 years
Allan Rasmussen	M	57	Technical University of Denmark	4 years
Henrik Jeberg	M	-	Technical University of Denmark	6 years
Michael Berggreen Petersen	M	-	Technical University of Denmark	3 years
Jacob Michelsen	M	-	Technical University of Denmark	5 years

Statistics

Country	Connections	% of total
Denmark	95	95.00%
United States	8	8.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections